In June 2021, Philips notified the ANSM of a field safety action that related to the potential risk of degradation and inhalation of carcinogenic compounds from the sound-absorbing foam used in its ventilation devices for...more
6/2/2023
/ Enforcement Actions ,
Failure to Comply ,
French National Drug and Health Product Agency (ANSM) ,
Healthcare ,
Injunctions ,
Life Sciences ,
Medical Devices ,
Patient Safety ,
Pharmaceutical Industry ,
Product Defects ,
Product Recalls ,
Regulatory Standards ,
Remedial Actions
The Administrative Supreme Court upholds decisions restricting the prescription of a treatment against osteoporosis.
Upon the assessment of a follow-up study, the French National Authority for Health (“HAS”) recommended...more
Since October 1, 2020, healthcare companies have been required to implement the new French anti-gift legal framework, as substantially strengthened by the Ordinance No. 2017-49 dated January 19, 2017....more
In the context of the pandemic, Decree No. 2020-1090 of 25 August 2020 on various measures relating to the reimbursement of health products (the “Decree”) could have been overseen as merely being a technical document. ...more